Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Emile M. Bellott is active.

Publication


Featured researches published by Emile M. Bellott.


Archive | 1995

Substituted tryptamines phenalkylamines and related compounds

Kay J. D'orlando; Kenneth W. Locke; Emile M. Bellott; Richard L. Gabriel; Michael D. Nohrden; Yesh P. Sachdeva; Salah A. Zahr; Emile Al-Farhan; Subramaniam Krishnananthan


Archive | 2002

Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist

Hermann Lübbert; Christoph Ullmer; Emile M. Bellott; Mark Froimowitz; Douglas Gordon


Archive | 2004

Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation

Carlo Brugnara; Jose A. Halperin; Rudolf Flückiger; Emile M. Bellott; Richard John Lombardy; John J. Clifford; Ying-Duo Gao; Reem M. Haidar; Eugene W. Kelleher; Adel M. Moussa; Yesh P. Sachdeva; Minghua Sun; Heather N. Taft


Archive | 2002

1-methyl-4-(3-ethoxy-9h-thioxanthene-9-ylidene)-piperidine and its use as 5-ht2b and/or h1 antagonist

Christoph Ullmer; Hermann Lübbert; Emile M. Bellott; Mark Froimowitz; Douglas Gordon


Archive | 2001

Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferation

Carlo Brugnara; Jose A. Halperin; Rudolf Flückiger; Emile M. Bellott; Richard John Lombardy; John J. Clifford; Ying-Duo Gao; Reem M. Haidar; Eugene W. Kelleher; Adel M. Moussa; Yesh P. Sachdeva; Minghua Sun; Heather N. Taft


Archive | 1998

Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation

Carlo Brugnara; Jose A. Halperin; Rudolf Flückiger; Emile M. Bellott; Richard John Lombardy; John J. Clifford; Ying-Duo Gao; Reem M. Haidar; Eugene W. Kelleher; Adel M. Moussa; Yesh P. Sachdeva; Minghua Sun; Heather N. Taft; Michael H Zeldin


Archive | 2003

1-Methyl-4- (3-ethoxy-9H-thioxanthene-9-ylidene) -piperidine and its use as 5-HT2B/H1 receptor antagonist

Christoph Ullmer; Hermann Lübbert; Mark Froimowitz; Emile M. Bellott; Douglas Gordon


Archive | 2002

4-(thio- oder selenoxanthen-9-yliden)-piperidin oder acridin derivate und ihre verwendung als selektive 5ht2b rezeptorantagonisten 4- (thio- or selenoxanthen-9-ylidene) piperidine or acridine derivatives and their use as selective receptor antagonists 5HT2B

Emile M. Bellott; Mark Froimowitz; Douglas Gordon; Hermann Lübbert; Christoph Ullmer


Archive | 2002

1-methyl-4-(3-ethoxy-9h-thioxanthene-9-ylidene)-piperidine et utilisation de celle-ci en tant qu'antagoniste de 5-ht2b et/ou h1

Christoph Ullmer; Hermann Lübbert; Emile M. Bellott; Mark Froimowitz; Douglas Gordon


Archive | 2000

***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation

Carlo Brugnara; Jose A. Halperin; Rudolf Flückiger; Emile M. Bellott; Richard John Lombardy; John J. Clifford; Ying-Duo Gao; Reem M. Haidar; Eugene W. Kelleher; Adel M. Moussa; Yesh P. Sachdeva; Minghua Sun; Heather N. Taft

Collaboration


Dive into the Emile M. Bellott's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carlo Brugnara

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge